Ackermans & van Haaren logo

Ackermans & van Haaren

Europe, Antwerpen, Belgium, Antwerpen

Description

Ackermans & van Haaren is a diversified group active in 5 key sectors: infrastructure and marine engineering, private banking, real estate.

Investor Profile

Ackermans & van Haaren has made 14 investments, with 3 in the past 12 months and 36% as lead.

Stage Focus

  • Series B (50%)
  • Series C (14%)
  • Series A (14%)
  • Post Ipo Equity (7%)
  • Series D (7%)
  • Seed (7%)

Country Focus

  • Belgium (57%)
  • India (29%)
  • The Netherlands (14%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • B2b
  • Marketplace
  • Pharmaceutical
  • Agriculture
  • Agtech
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ackermans & van Haaren frequently co-invest with?

AI
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 3
KI
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
Droia Ventures
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 2
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 4
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 3
HealthQuad
Asia, Delhi, India, New Delhi
Co-Investments: 3
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 2
Capricorn Partners
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3

Which angels does Ackermans & van Haaren often collaborate with?

Sunil Kalra
Asia, Delhi, India, New Delhi
Shared Deals: 1
AV
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Ackermans & van Haaren?

Biotalys

Ghent, Oost-Vlaanderen, Belgium

Biotalys is an AgTech company that employs its proprietary AGROBODY™ technology platform to develop crop protection products.

AgricultureAgTechBiotechnology
Post Ipo EquityOct 14, 2024
Amount Raised: $16,364,255
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
Series BJul 26, 2024
Amount Raised: $65,148,419
Vico Therapeutics

Leiden, Zuid-Holland, The Netherlands

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

Health CareMedicalPharmaceutical
Series BJun 24, 2024
Amount Raised: $12,298,137
Vico Therapeutics

Leiden, Zuid-Holland, The Netherlands

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

Health CareMedicalPharmaceutical
Series BJan 5, 2024
Amount Raised: $72,081,941
AstriVax

Heverlee, Vlaams-Brabant, Belgium

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

Clinical TrialsMedical
SeedAug 25, 2022
Amount Raised: $29,912,416
Medikabazaar

Mumbai, Maharashtra, India

Medikabazaar is an online B2B marketspace for medical supplies and equipment.

B2BHealth CareMarketplaceMedical Device
Series DApr 12, 2022
Amount Raised: $64,872,006
Medikabazaar

Mumbai, Maharashtra, India

Medikabazaar is an online B2B marketspace for medical supplies and equipment.

B2BHealth CareMarketplaceMedical Device
Series CSep 22, 2021
Amount Raised: $58,612,409
Indigo Diabetes

Zwijnaarde, Oost-Vlaanderen, Belgium

Indigo Diabetes is a medtech company that develops a multi-biomarker sensor for people with diabetes.

DiabetesHealth CareMedicalMedical Device
Series BJul 27, 2020
Amount Raised: $44,724,088
Medikabazaar

Mumbai, Maharashtra, India

Medikabazaar is an online B2B marketspace for medical supplies and equipment.

B2BHealth CareMarketplaceMedical Device
Series BJun 18, 2020
Amount Raised: $3,350,713
MRM Health NV

Ghent, Oost-Vlaanderen, Belgium

MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.

BiotechnologyHealth CarePharmaceutical
Series AFeb 19, 2020
Amount Raised: $15,133,728